Exelixis (EXEL) Interest & Investment Income (2017 - 2026)

Exelixis (EXEL) recorded quarterly Interest & Investment Income of $16.1 million in Q2 2026, down 7.45% quarter-over-quarter from $17.4 million in Q1 2026, and down 15.46% on a YoY basis from $19.1 million in Q2 2025.

Exelixis (EXEL) Interest & Investment Income (2017 - 2026) Analysis & Trends

Exelixis' Interest & Investment Income history runs 10 years deep, the most recent figure standing at $16.1 million for Q2 2026.

  • In Q2 2026, Interest & Investment Income fell 15.46% year-over-year to $16.1 million; the TTM figure through Apr 2026 stood at $66.3 million (down 13.2% YoY), while the FY2026 annual figure was $69.2 million, down 10.29% from the prior year.
  • Interest & Investment Income was $16.1 million for Q2 2026 at Exelixis, down from $17.4 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $23.1 million in Q3 2023 to a low of $1.8 million in Q2 2022.
  • Historically, Interest & Investment Income has averaged $16.6 million across 5 years, with a median of $17.4 million in 2026.
  • Biggest YoY gain for Interest & Investment Income was 1078.9% in 2022; the steepest drop was 32.07% in 2022.
  • A 5-year view of Interest & Investment Income shows it stood at $17.0 million in 2022, then increased by 25.9% to $21.4 million in 2023, then decreased by 12.53% to $18.7 million in 2024, then fell by 14.9% to $15.9 million in 2025, then gained by 1.29% to $16.1 million in 2026.
  • The last three Interest & Investment Income figures came in at $16.1 million (Q2 2026), $17.4 million (Q1 2026), and $15.9 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 597,319.59
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 40.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 305,000.00
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 103,341.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 114.80 Mn
9 Abivax 91.71 Bn 91.71 Bn - -14.79 Mn
10 Exelixis 13.61 Bn 12.83 Bn 590.86 Mn 16.13 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 16.13 Mn
Jan 2, 2026 17.43 Mn
Oct 3, 2025 15.92 Mn
Jul 4, 2025 16.79 Mn
Apr 4, 2025 19.08 Mn
Jan 3, 2025 21.30 Mn
Sep 27, 2024 18.71 Mn
Jun 28, 2024 17.26 Mn
Mar 29, 2024 19.89 Mn
Dec 29, 2023 21.39 Mn
Sep 29, 2023 23.11 Mn
Jun 30, 2023 22.54 Mn
Mar 31, 2023 19.50 Mn
Dec 30, 2022 16.99 Mn
Sep 30, 2022 9.50 Mn
Jul 1, 2022 4.76 Mn
Apr 1, 2022 1.82 Mn
Dec 31, 2021 1.44 Mn
Oct 1, 2021 1.66 Mn
Jul 2, 2021 1.89 Mn